Tag: Links

$2.2 trillion deficit in 2021. Adverse selection and ACA plans. COVID-19 and panic drug purchasing. Amazon: $6 six-month prescriptions Pharmacist’s opinion on value-based comprehensive medication management

Administrative simplicity vs. single payer. 340B case heads to the Supreme Court. Marketing and mammograms NY ends state of emergency: what happens to out-of-state licensed health care professionals? Key facts on the Delta Variant.

Evaluating the robustness of CMS Hospital VBP measurement system. ICER’s gene therapy evaluations. Who are high-frequency hospital users? EHR and malpractice. What is Evio? Has in vivo gene editing come of age?

Why the FDA approved aducanumab.  How to report changes in clinical trial protocols due to COVID-19 (CONSERVE) Democrats eye Medicare and Medicaid expansions. ACA and biosimilars. The challenges of improving quality of care. Native Americans and health equity.

Supreme court upholds ACA. Nature on lab-leak hypothesis. The geography of global warming. The return of boarding houses.  Business perspective on single payer.

Physician compensation during the pandemic. Caring for an aging nation. The debt snowball. Infection rate among the unvaccinated is as high as it was back in January CMS all-in on mandatory pay-for-performance reimbursement. Patients minimize cost by reducing Q, not trying to minimize P.

Affordability vs. Innovation. “standardizing contracts generates larger savings with less variance than savings from single‐payer strategies” The placebo effect examined Income growth in knowledge industries. Alcohol sales restrictions and alcohol poisoning mortality.

LGBTQ Economics. Does health insurance improve health outcomes for cancer patients? Shattered. Mr. Jim. KHN: “Moderna…announced in October that it would not enforce its covid-related patents during the pandemic. Even so, no known independent producer has used the available patents to replicate the company’s mRNA vaccine. Experts say that’s telling.”

Disability and distress. COVID-19 vaccine showdown: California vs. Texas. Opioid trajectories. “beliefs…are insufficiently skeptical about nondisclosed information in the absence of repeated feedback” What is ARPA-H?

ACA ‘family glitch’ Hospital price transparency.  NBA players and COVID-19. Good work if you can get it. SPACs and digital health. Dark chocolate is not a superfood.